"Hybrid" lesion of desmoplastic and conventional ameloblastoma: Immunohistochemical aspects

Brazilian Journal of Otorhinolaryngology

Volumn 72, Issue 5, 2006, Pages 709-713

  Dos Santos, Jean Nunes ^a   De Souza, Veronica Ferreira ^a   Azevêdo, Roberto Almeida ^a   Sarmento, Viviane Almeida ^a   Souza, Lélia Batista ^a  

^a NONE

Author keywords

Ameloblastoma; Extracellular matrix

Indexed keywords

COLLAGEN TYPE 1; FIBRONECTIN; SCLEROPROTEIN; TENASCIN;

ADULT; AMELOBLASTOMA; ARTICLE; CONTROLLED STUDY; FEMALE; FIBROMA; FOLLICULAR CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAW TUMOR; MALE; ODONTOGENIC CYST;

EID: 33751394414     PISSN: 18088694     EISSN: 18088686     Source Type: Journal    
DOI: 10.1016/S1808-8694(15)31030-2     Document Type: Article

References (15)

1. Eversole LR, Leider AS, Hansen LS. Ameloblastomas with pronounced desmoplasia. J Oral Maxillofac Surg 1984;42:735-40.
2. Waldron CA, El-Mofty SM. A histopathologic study of 116 ameloblastomas with special reference to desmoplastic variant. Oral Surg Oral Med Oral Pathol 1987;63:441-51.
3. Takata T, Ogawa I, Zhao M, Kudo Y, Sato S, Takekoshi T et al. So-called "hybrid" lesion of desmoplastic and conventional ameloblastoma: report of a case and review of the literature. Pathol Int 1999;49:1014-8.
4. Chiquet-Ehrishman R, Mackie EJ, Pearson CA, Sakakura T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 1986;47:131-9.
5. Takata T, Miyauchi M, Ito H, Ogawa I, Kudo Y, Zhao M et al. Clinical and histopathological analyses of desmoplastic ameloblastoma. Pathol Res Pract 1999;195:660-75.
6. Kishino M, Murakami S, Fukuda Y, Ishida T. Pathology of the desmoplastic ameloblastoma. J Oral Pathol Med 2001;30:35-40.
7. Lam KY, Chan ACL, Wu PC, Chau KY, Tiedman H, Wei W. Desmoplastic variant of ameloblastoma in Chinese patients. B J Oral Maxillofac Surg 1998;36:129-34.
8. Phillipsen HP, Ormiston IW, Reichart PA. The desmo- and osteoplastic ameloblastoma Histologic variant or clinicopathologic entity? Case reports. J Oral Maxillofac Surg 1992;21:352-7.
9. Philipsen HP, Reichart PA, Slootweg PJ, Slater LJ. In: Barnes L, Eveson JW, Reichart P, Sidransky S. World Health Organization Classification of Tumours, Pathology & Genetics. Head and Neck and Tumours. 1st ed. Lyon: IARC Press; 2005. p. 285-6.
10. Phillipsen HP, Reichart PA, Takata T. Desmoplastic ameloblastoma (including "hybrid" lesion of ameloblastoma) Biological profile based on 100 cases from the literature and own files. Oral Oncol 2001;37:455-60.
11. Beckley MI, Farhood V, Helfend LK, Alijanian A. Desmoplastic ameloblastoma of the mandible: a case report and review of the literature. J Oral Maxillofac Surg 2002;60:194-8.
12. Mori M, Yamada T, Doi T, Ohmura Y, Takai Y, Shrestha P. Expression of tenascin in odontogenic tumours. Oral Oncol Eur J Cancer 1995;31B:275-9.
13. Medeiros AMC. Expressão da fibronectina tenascina e colágeno I em ameloblastoma e no tumor odontogênico adenomatóide (Tese de Doutorado). Natal, Universidade Federal do Rio Grande do Norte, 2001.
14. Heikinheimo K, Morgan PR, Happonem R-P, Stenman G, Virtaneu I. Distribution of extacellular marix proteins in odontogenic umours and developing teeth. Virchows Arch B Cell Pathol 1991;61:101-9.
15. Slavkin HC. Molecular determinants during dental morphogenesis and cytodifferentiation: a review. J Craniofac Genet Dev Biol 1991;11:338-49.